Confined placental mosaicism for trisomy 14 and maternal uniparental disomy in association with elevated second trimester maternal serum human chorionic gonadotrophin and third trimester fetal growth restriction.
A case of confined placental mosaicism (CPM) and maternal uniparental isodisomy 14 identified after placental karyotype revealed trisomy 14 in a newborn with intrauterine growth restriction (IUGR) and minor dysmorphic features is reported. During the second trimester of the pregnancy, multiple marker screening revealed an increased risk for Down syndrome of > 1 in 10. The maternal serum human chorionic gonadotrophin (MShCG) was markedly elevated at 4.19 MoM. Amniocentesis revealed a normal 46,XX karyotype. Fetal growth restriction has been associated with elevated MShCG and placental aneuploidy with CPM for chromosomes 2, 7, 9 and 16. The present case of CPM for chromosome 14 was also associated with fetal growth restriction and elevated second trimester MShCG, suggesting a common link. Further studies need to be done to determine if indeed elevation of second trimester MShCG is associated with increased risk of CPM. The present case again demonstrates the need to perform placental karyotype in unexplained fetal growth restriction.
Towner
D R
DR
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine and Pediatrics, University of California Davis, Sacramento, CA 95817, USA. drtowner@ucdavis.edu
Shaffer
L G
LG
Yang
S P
SP
Walgenbach
D D
DD
D000328:Adult; D000649:Amniocentesis; D000653:Amniotic Fluid / Q000166:cytology; D006063:Chorionic Gonadotropin / Q000097:blood*; D002883:Chromosomes, Human, Pair 14; D005260:Female; D005317:Fetal Growth Retardation; D005819:Genetic Markers; D006801:Humans; D007231:Infant, Newborn; D009030:Mosaicism / Q000235:genetics* / Q000473:pathology; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D014314:Trisomy
D006063:Chorionic Gonadotropin; D005819:Genetic Markers